01299 AIA Group Limited

DGAP-News: AIA Agrees Exclusive Asia-Pacific Regional Partnership with Medix

DGAP-News: AIA Group Limited / Key word(s): Agreement
AIA Agrees Exclusive Asia-Pacific Regional Partnership with Medix (news with additional features)

20.05.2019 / 17:45
The issuer is solely responsible for the content of this announcement.


img

img
 

AIA Agrees Exclusive Asia-Pacific Regional Partnership with Medix

Breakthrough regional partnership between AIA and Medix, a company specialising in quality global medical management, to provide improved healthcare and clinical outcomes for AIA customers

 

HONG KONG, CHINA - - 20 May 2019 - AIA Group Limited ("AIA" or the "Company": stock code: 1299) announced today that its customers across the Asia-Pacific region are set to benefit from a landmark partnership agreement with global health management company Medix. AIA and Medix are partnering to deliver a differentiated proposition that optimises care and improves medical outcomes for AIA customers across the region. Under the expanded regional partnership, building on already successful collaborations between AIA and Medix in Hong Kong and Singapore, AIA and Medix will work together to launch in more markets in 2019, including Indonesia, Malaysia, Thailand and Australia. Additional markets are planned for launch in 2020 and beyond.

Under the exclusive partnership with Medix, selected AIA customers will have access to "Personal Medical Case Management Services" during some of the most challenging times of their lives. When diagnosed with a serious or complex condition AIA customers will be supported by a dedicated case team throughout their medical journey, from diagnosis through treatment until full recovery. They will gain access to a holistic medical assessment, re-evaluation of their condition, referral for additional diagnostic testing - where needed, ongoing multi-disciplinary consultations, full care coordination, on-going guidance and emotional support provided by Medix' team of renowned medical experts from around the globe.

Eligible AIA customers will have their medical case reviewed by Medix' expert team of 300
in-house physicians and a global quality accredited network of over 3,000 world-leading and independent medical specialists, ensuring they have the tools to make educated, quality driven decisions and receive the best possible care throughout their medical journey, anywhere in the world.

Ng Keng Hooi, AIA's Group Chief Executive and President, said the announcement underscores AIA's commitment to meet the growing and changing needs of customers and to help people live Healthier, Longer, Better Lives.

"With the advances in medical treatments and technologies, the expectations of Asian consumers have changed significantly, with personalised, quality medical care at the top of their list. This strategic partnership with Medix exemplifies our leadership role in driving economic and social development across the region. It demonstrates our pledge to go beyond the traditional, passive insurance business model by becoming an integral part of our customers' life journey" he said.

Mark Saunders, AIA's Group Chief Strategy and Corporate Development Officer with responsibility for healthcare underlined AIA's strategy and deliberate investment in helping improve the health and well-being of its customers, saying "AIA's expanded partnership with Medix represents a significant step forward in delivering our long-term strategic vision in the health and well-being space, where we've invested significantly and consistently over the past several years. It builds on a highly successful partnership in Hong Kong and Singapore, where we've been able to provide Medix' unparalleled medical case management services to our customers.

"To successfully deliver on our vision to help people be healthier for longer we are building an eco-system of services and partners to help people on all steps of the health journey through predict, prevent, diagnose, treat and recover stages, improving their overall wellbeing. Our exclusive partnership with Medix across our markets enhances AIA's distinctive and differentiated proposition in health and well-being. By providing our policyholders with Personal Medical Case Management AIA helps overcome local healthcare disparities and makes international expertise, locally available through a mutually beneficial collaborative process" Saunders said.

Sigal Atzmon, CEO of Medix commended AIA's visionary and innovative approach to driving meaningful improvements in people's lives across the region.

"This is a partnership that will make a genuine difference; it represents a shared vision and a commitment to reduce unwarranted healthcare variations across the region, improve the medical accessibility, medical outcomes and most importantly, improve the overall care experience" Ms Atzmon said.

"Through this partnership, we provide personalised medical care, empower patients with the knowledge and tools they deserve to make educated decisions and offer active coverage in the daily lives of each policyholder. As such, we are enabling an unprecedented democratisation of the entire healthcare landscape.

"AIA, as one of the world's largest and leading insurers should be applauded for the courageous, pioneering spirit they have shown over the last 100 years. Their vision and commitment to improving the lives of their customers/people across the region is unwavering and we are honoured to be a part of their next chapter," Ms Atzmon concluded.

- End -

About AIA

AIA Group Limited and its subsidiaries (collectively "AIA" or the "Group") comprise the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets in Asia-Pacific - wholly-owned branches and subsidiaries in Hong Kong, Thailand, Singapore, Malaysia, China, Korea, the Philippines, Australia, Indonesia, Taiwan, Vietnam, New Zealand, Macau, Brunei, Cambodia, a 97 per cent subsidiary in Sri Lanka, a 49 per cent joint venture in India and a representative office in Myanmar.

The business that is now AIA was first established in Shanghai a century ago in 1919. It is a market leader in the Asia-Pacific region (ex-Japan) based on life insurance premiums and holds leading positions across the majority of its markets. It had total assets of US$230 billion as of 31 December 2018.

AIA meets the long-term savings and protection needs of individuals by offering a range of products and services including life insurance, accident and health insurance and savings plans. The Group also provides employee benefits, credit life and pension services to corporate clients. Through an extensive network of agents, partners and employees across Asia-Pacific, AIA serves the holders of more than 33 million individual policies and over 16 million participating members of group insurance schemes.

AIA Group Limited is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code "1299" with American Depositary Receipts (Level 1) traded on the over-the-counter market (ticker symbol: "AAGIY").

About Medix Medical Services

Established in 2006, the Medix Group is a global, leading provider of innovative, high quality health management solutions. With offices in London, Hong Kong, Shanghai, Singapore, Tel Aviv, Jakarta, Kuala Lumpur, Bangkok and Melbourne and a client base exceeding 3 million members in over 90 countries, Medix offers its clients -- primarily global health & life insurers, financial groups, large corporates and government institutions -- significant value-added services in the world of healthcare. Medix' medical team is comprised of 300 in-house doctors alongside nurses, research experts, medical administration teams and a quality accredited global network of over 3,000 specialists and 1,500 leading hospitals.

Through its various services, Medix offers its customers fast-track solutions to proven better medical outcomes. Medix provides Global Personal Case Management Services, Disease Prevention Management Services, Digital Health Solutions, Home Care Services, Health Strategy and Medical Governance Services to insurers, large corporates and government institutions.

Medix is a Shared Value company that strives to enable people around the world to have access to the best medical care possible while eliminating unwarranted healthcare variations and helping to control medical cost inflation. Believing that the accessibility, quality and sustainability of medical care are one of the most important components of social rights, Medix is very passionate about these issues and is globally fully dedicated to these activities.

Contacts
AIA Group Limited Medix
Stephen Thomas Shay Keinan
Mark Walters Ashley Bailey
Emerald Ng    

Additional features:

Document:
Document title: Medix_AIA_Group_Photo


20.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


813637  20.05.2019 

fncls.ssp?fn=show_t_gif&application_id=813637&application_name=news&site_id=research_pool
EN
20/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AIA Group Limited

Bella Lu Yifei ... (+4)
  • Bella Lu Yifei
  • Curtis Yeung
  • Greater China Research Team
  • Ken Lee

Greater China Daily: Friday, February 20, 2026

Top Stories Sector Update | Automobile As of mid-Feb 26, over 20 Chinese provinces and cities have announced 2026 vehicle purchase subsidy schemes, aligning with the national policy that has shifted to percentage-based subsidies (favouring mid-range to high-end vehicles) from 2025’s fixed amounts. This supports premium segments and market stability but may not fully counter the new 5% EV tax. 2026 sales forecasts: PV ‒ 30.4m units (+3% yoy); PEV ‒ 18.2m units (+19% yoy). Maintain MARKET WEIGHT. ...

Greater China Research Team ... (+2)
  • Greater China Research Team
  • Tham Mun Hon

AIA Group (1299 HK): Eyeing Solid 2025 Results.

Despite some pullback in Hong Kong and Thailand, we still expect AIA to deliver a 16% VONB growth in 4Q25, bringing full-year VONB growth to 19%. EV per share is projected to grow 13%, thanks to a solid VONB contribution and favourable macro tailwinds. We also foresee OPAT per share rising 12% yoy, on track to achieve management’s growth target. Maintain BUY with a higher target price of HK$109.00 following the positive revision of our VONB and EV forecasts.

Claire Wang Kelai ... (+7)
  • Claire Wang Kelai
  • Curtis Yeung
  • Gigi Cheuk
  • Greater China Research Team
  • Joyce Chu
  • Kate Luang
  • Tham Mun Hon

Greater China Daily: Wednesday, February 11, 2026

Top Stories Strategy | Small/Mid Cap Monthly ‒ 2025 Results Preview We expect names under our coverage to report resilient earnings growth for 2025. For names with generous dividend payouts, we are eyeing the possibilities of special dividends for 2025 on the back of robust balance sheets and solid results: Crystal, Plover Bay, SHK& Co. We are also monitoring capex plans for Crystal and Kingboard Laminates. Our most preferred pick is Crystal, given its attractive valuation (10.2x 2026F PE, 6.4%...

Adrian Loh Tzum Yung ... (+16)
  • Adrian Loh Tzum Yung
  • Alden Gabriel Lam
  • Amerul Iqmal
  • Benjaphol Suthwanish
  • Benyamin Mikael
  • Claire Wang Kelai
  • Gigi Cheuk
  • Greater China Research Team
  • Jack Goh Tooan Orng
  • Joyce Chu
  • Kate Luang
  • Lester Siew
  • Tanapon Cholkadidamrongkul
  • Tanaporn Visaruthaphong
  • Tham Mun Hon
  • Wei Xiang Ku

Regional Morning Meeting Notes: Wednesday, February 11, 2026

Greater China Strategy | Small/Mid Cap Monthly ‒ 2025 Results Preview We expect names under our coverage to report resilient earnings growth for 2025. For names with generous dividend payouts, we are eyeing the possibilities of special dividends for 2025 on the back of robust balance sheets and solid results: Crystal, Plover Bay, SHK& Co. We are also monitoring capex plans for Crystal and Kingboard Laminates. Our most preferred pick is Crystal, given its attractive valuation (10.2x 2026F PE, 6.4...

Greater China Research Team ... (+5)
  • Greater China Research Team
  • Johnny Yum
  • Malaysia Research Team
  • Singapore Research Team
  • Thailand Research Team

Regional Strategy: Alpha Picks - December 2025

Greater China Strategy | Alpha Picks: December Conviction Calls Market consolidation slowed in November as expectations of a 25bp Fed cut buoyed sentiment. The HSI and MSCI China fell 0.2% and 2.4% mom respectively amid weak data and limited catalysts. While the upcoming Economic Work Conference may offer a catalyst to end this phase, we remain cautious, preferring defensives and oversold names. We add BeOne Medicines, HKEX, NetEase and Plover Bay to BUY, take profit on AIA, and cut losses on Ja...

MAJOR MAJOR CINEPLEX GROUP PCL
OU8 CENTURION
544 CSE GLOBAL LTD.
CTRA CIPUTRA DEVELOPMENT
EGCO ELECTRICITY GENERATING PUBLIC CO. LTD.
BBRI PT BANK RAKYAT INDONESIA (PERSERO) TBK CLASS B
V03 VENTURE CORPORATION LIMITED
ERW ERAWAN GROUP
EZQ CHINA MENGNIU DAIRY CO. LTD.
U96 SEMBCORP INDUSTRIES LTD.
B8O YANGZIJIANG SHIPBUILDING (HOLDINGS) LTD.
SXC SUNNY OPTICAL TECHNOLOGY (GROUP) CO. LTD.
JSMR PT JASA MARGA (PERSERO) TBK CLASS B
00285 BYD ELECTRONIC (INTERNATIONAL) CO. LTD.
01299 AIA GROUP LIMITED
00027 GALAXY ENTERTAINMENT GROUP LIMITED
3816 MISC BHD
BMRI PT BANK MANDIRI (PERSERO) TBK
KBANK KASIKORNBANK PUBLIC CO. LTD.
7113 TOP GLOVE CORPORATION BHD.
O39 OVERSEA-CHINESE BANKING CORPORATION LIMITED
601668 CHINA STATE CONSTRUCTION ENGINEERING CORP. LTD. CLASS A
X2S SINOPHARM GROUP CO. LTD. CLASS H
599A SANDS CHINA LTD.
CPN CENTRAL PATTANA PUBLIC CO. LTD.
ASII PT ASTRA INTERNATIONAL TBK
00700 TENCENT HOLDINGS LTD.
TRUE TRUE CORP. PUBLIC CO. LTD.
2318 PING AN INSURANCE (GROUP) COMPANY OF CHINA LTD. CLASS H
SATS SP SATS LTD.
D01 DAIRY FARM INTERNATIONAL HOLDINGS LIMITED
G13 GENTING SINGAPORE LIMITED
03690 MEITUAN CLASS B
RHBBANK RHB BANK BHD
GAM GAMUDA BHD
VSI V.S. INDUSTRY BERHAD
3933 THE UNITED LABORATORIES INTE
MYEG MY EG SERVICES BHD
MINT MAPLETREE INDUSTRIAL TRUST
CPALL TB CP ALL
SDPL SIME DARBY PLANTATION BHD
ECW ECO WORLD DEVELOPMENT GROUP
RATCH RATCH GROUP PUBLIC CO. LTD.
02232 CRYSTAL INTERNATIONAL GROUP
2013 WEIMOB INC
RGB RGB INTERNATIONAL BHD
WHA TB WHA CORP PCL
MPM MARCO POLO MARINE LTD
CSSC CHINA SUNSINE CHEMICAL HOLDINGS LTD
LREIT SP LENDLEASE GLOBAL COMMERCIAL REIT
3692 HANSOH PHARMACEUTICAL GROUP
MNSO MINISO GROUP HOLDING ADS (N SHARES)
CVL CIVMEC
002920 HUIZHOU DESAY SV AUTOMOTIVE CO LTD
02618 JD LOGISTICS INC
BBTN BANK TABUNGAN NEGARA PERSERO TBK PT
BBNI BANK NEGARA INDONESIA PERSER
CMRY PT CISARUA MOUNTAIN DAIRY TBK
ITC I-TAIL CORPORATION PUBLIC COMPANY LIMITED
STM SEATRIUM LTD
NCKL PT TRIMEGAH BANGUN PERSADA TBK (HARITA NICKEL)
YINSON YINSON HOLDINGS BHD
09961 CTRIP.COM INTERNATIONAL
BTG BETAGRO PUBLIC COMPANY LIMITED
LAGENDA LAGENDA PROPERTIES BHD
PEKAT PEKAT GROUP BHD
1523 PLOVER BAY TECHNOLOGIES LTD (1523 HK)
GEELY GEELY AUTOMOBILE
EXCL XLSMART TELECOM SEJAHTERA

ResearchPool Subscriptions

Get the most out of your insights

Get in touch